Keros Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
KROS Nasdaq 2830 www.kerostx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Keros Therapeutics, Inc.

INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced - Jan 12th, 2026 7:32 am
This Health Name Gains Over 400% In 2025. A Gold Stock Is Right Behind It. - Jan 2nd, 2026 10:40 am
Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics - Jan 2nd, 2026 2:32 am
KROS or ARGX: Which Is the Better Value Stock Right Now? - Dec 30th, 2025 9:40 am
Keros Therapeutics (KROS) Upgraded to Strong Buy: Here's Why - Dec 22nd, 2025 10:00 am
Here's Why Keros Therapeutics (KROS) Could be Great Choice for a Bottom Fisher - Dec 22nd, 2025 7:55 am
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026 - Dec 16th, 2025 7:23 am
Zacks.com featured highlights include StoneCo, General Motors, Enersys, Deutsche, Keros - Dec 16th, 2025 2:02 am
What Makes Keros Therapeutics, Inc. (KROS) a Strong Momentum Stock: Buy Now? - Dec 12th, 2025 10:00 am
KROS vs. ARGX: Which Stock Is the Better Value Option? - Dec 12th, 2025 9:40 am
KROS or NVZMY: Which Is the Better Value Stock Right Now? - Nov 26th, 2025 9:40 am
How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24% - Nov 26th, 2025 7:55 am
Keros Therapeutics Announces Final Results of Tender Offer - Nov 20th, 2025 2:01 pm
Keros Therapeutics Announces Preliminary Results of Tender Offer - Nov 19th, 2025 4:00 am
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - Nov 10th, 2025 7:55 am
Earnings Update: Keros Therapeutics, Inc. (NASDAQ:KROS) Just Reported And Analysts Are Boosting Their Estimates - Nov 9th, 2025 5:10 am
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates - Nov 5th, 2025 3:40 pm
Keros Therapeutics Reports Third Quarter 2025 Financial Results - Nov 5th, 2025 2:01 pm
Keros Therapeutics (KROS) Moves 9.8% Higher: Will This Strength Last? - Oct 21st, 2025 7:43 am
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday on Interest Rate Cut Expectations - Oct 15th, 2025 6:49 am